Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Receives Consensus Rating of “Hold” from Analysts
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) have earned an average rating of “Hold” from the six research firms that are presently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and two have assigned a buy recommendation […]
22 Nov 16:50 · The Markets Daily